Save Comparison | ![]() Vitality Biopharma Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions. | ![]() Futura Medical Futura's innovation strategy applies advanced science to develop products with compelling commercial potential. | ![]() Adamas Pharmaceuticals Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders. | ![]() Generex Biotechnology Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases. | ![]() Opiant Pharmaceuticals Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders. |
Founding Date | Founding Date 2012 | Founding Date 1997 | Founding Date 2002 | Founding Date N/A | Founding Date 2009 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Los Angeles, US HQ | Locations Guildford, GB HQ | Locations Emeryville, US HQ | Locations Burlington, CA HQ Miramar, US | Locations Santa Monica, US HQ London, GB Santa Monica, US |
Employees | Employees 814% increase | Employees 13 | Employees 1361% increase | Employees 9200% increase | Employees 2131% increase |
Valuation ($) | Valuation ($) 4.6 m | Valuation ($) 50.4 m | Valuation ($) 134.6 m | Valuation ($) 46.2 m | Valuation ($) 39.7 m |
Twitter followers | Twitter followers N/A | Twitter followers 62 | Twitter followers N/A | Twitter followers 766 | Twitter followers N/A |
Alexa Website Rank | Alexa Website Rank 232134 | Alexa Website Rank 193950 | Alexa Website Rank 150475 | Alexa Website Rank 358312 | Alexa Website Rank 331763 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.8 | Employee Rating 3 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $54.6m (FY, 2019) | Revenue (est.) $6.2m (FY, 2019) | Revenue (est.) $40.5m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.5m (FY, 2019) | Cost of goods $4.1m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $52.2m (FY, 2019) | Gross profit $2.1m (FY, 2019) | Gross profit $40.5m (FY, 2019) |
Net income | Net income ($4.4m) (FY, 2020) | Net income (£5.9m) (FY, 2018) | Net income ($105.2m) (FY, 2019) | Net income ($11m) (FY, 2019) | Net income $11.6m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 18.2m | Total funding raised $ 82m | Total funding raised N/A | Total funding raised N/A |
Futura's innovation strategy applies advanced science to develop products with compelling commercial potential.
View companyAdamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
View companyGenerex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
View companyOpiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
View company